All news

Harvard Bioscience forms five-member scientific advisory board

Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash

Harvard Bioscience has formed a five-member scientific advisory board to guide its research, development and new product roadmaps, with quarterly meetings planned. The move follows Q2 revenue of $22.73 million that surpassed analyst estimates, plus an ownership filing showing a 5.20 percent stake. Investors await the Q3 earnings report on November 10, 2026, to gauge the operational impact.

Read original source

HBIO company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.